HES
44
4
HD
43
-3
GPC
41
-3
KSS
37
3
HAL
34
5
NFLX
74
-2
VIX
27
-8
MUR
33
4
EW
37
-4
ED
34
-3
PRGO
37
2
HAS
57
2
ZBH
53
2
SCHW
59
-8
TXT
70
2
URI
59
3
ADP
79
2
F
34
2
GRMN
59
3
PPG
50
3
HES
44
4
HD
43
-3
GPC
41
-3
KSS
37
3
HAL
34
5
NFLX
74
-2
VIX
27
-8
MUR
33
4
EW
37
-4
ED
34
-3
PRGO
37
2
HAS
57
2
ZBH
53
2
SCHW
59
-8
TXT
70
2
URI
59
3
ADP
79
2
F
34
2
GRMN
59
3
PPG
50
3
Financhill
Back

John Hancock Financial Opportunities Fund Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
66

BTO
John Hancock Financial Opportunities Fund

Last Price:
$34.89
Seasonality Move:
-0.56%
Buy
59

SRPT
Sarepta Therapeutics

Last Price:
$39.68
Seasonality Move:
16.74%
Buy
66
John Hancock Financial Opportunities Fund (BTO) is a Buy

Is John Hancock Financial Opportunities Fund a Buy, Sell or Hold?

  • The current John Hancock Financial Opportunities Fund [BTO] share price is $34.50. The Score for BTO is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • BTO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
59
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $43.01. The Score for SRPT is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BTO Stock Price Chart

What is John Hancock Financial Opportunities Fund's stock price today?

  • The John Hancock Financial Opportunities Fund share price today is $34.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BTO is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $43.01
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

BTO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.36 Buy
Relative Strength Index (14 RSI): 59.73 Buy
Chaikin Money Flow: 2799 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.3 - 34.66) Buy
Bollinger Bands (100): (31.8 - 36.54) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.28 Sell
Relative Strength Index (14 RSI): 49.38 Sell
Chaikin Money Flow: 3187482 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.07 - 47.59) Buy
Bollinger Bands (100): (46.72 - 108.22) Sell

BTO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.18 Buy
20-day SMA: 34.26 Buy
50-day SMA: 32.68 Buy
200-day SMA: 34.49 Buy
8-day EMA: 34.2 Buy
20-day EMA: 33.93 Buy
50-day EMA: 33.56 Buy
200-day EMA: 33.52 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.98 Buy
20-day SMA: 38.06 Buy
50-day SMA: 49.42 Sell
200-day SMA: 101.51 Sell
8-day EMA: 39.68 Buy
20-day EMA: 41.1 Buy
50-day EMA: 52.44 Sell
200-day EMA: 89.96 Sell

John Hancock Financial Opportunities Fund Earnings Growth & BTO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.74 per share, an increase next quarter of $0.95 per share, a decrease this year of $3.92 per share, and an increase next year of $7.74 per share.

John Hancock Financial Opportunities Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):